Global Daratumumab Market Growth 2023-2029

March 2023 | 72 pages | ID: G0C95D081FFEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Daratumumab Industry Forecast” looks at past sales and reviews total world Daratumumab sales in 2022, providing a comprehensive analysis by region and market sector of projected Daratumumab sales for 2023 through 2029. With Daratumumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Daratumumab industry.

This Insight Report provides a comprehensive analysis of the global Daratumumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Daratumumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Daratumumab market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Daratumumab and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Daratumumab.

The global Daratumumab market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Daratumumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Daratumumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Daratumumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Daratumumab players cover Johnson?Johnson. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Daratumumab market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• 100mg Injection
• 400mg Injection

Segmentation by application

• Multiple Myeloma
• Diffuse Large B Cell Lymphoma
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Johnson?Johnson

Key Questions Addressed in this Report

What is the 10-year outlook for the global Daratumumab market?

What factors are driving Daratumumab market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Daratumumab market opportunities vary by end market size?

How does Daratumumab break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Daratumumab Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Daratumumab by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Daratumumab by Country/Region, 2018, 2022 & 2029
2.2 Daratumumab Segment by Type
  2.2.1 100mg Injection
  2.2.2 400mg Injection
2.3 Daratumumab Sales by Type
  2.3.1 Global Daratumumab Sales Market Share by Type (2018-2023)
  2.3.2 Global Daratumumab Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Daratumumab Sale Price by Type (2018-2023)
2.4 Daratumumab Segment by Application
  2.4.1 Multiple Myeloma
  2.4.2 Diffuse Large B Cell Lymphoma
  2.4.3 Follicular Lymphoma
  2.4.4 Mantle Cell Lymphoma
  2.4.5 Other
2.5 Daratumumab Sales by Application
  2.5.1 Global Daratumumab Sale Market Share by Application (2018-2023)
  2.5.2 Global Daratumumab Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Daratumumab Sale Price by Application (2018-2023)

3 GLOBAL DARATUMUMAB BY COMPANY

3.1 Global Daratumumab Breakdown Data by Company
  3.1.1 Global Daratumumab Annual Sales by Company (2018-2023)
  3.1.2 Global Daratumumab Sales Market Share by Company (2018-2023)
3.2 Global Daratumumab Annual Revenue by Company (2018-2023)
  3.2.1 Global Daratumumab Revenue by Company (2018-2023)
  3.2.2 Global Daratumumab Revenue Market Share by Company (2018-2023)
3.3 Global Daratumumab Sale Price by Company
3.4 Key Manufacturers Daratumumab Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Daratumumab Product Location Distribution
  3.4.2 Players Daratumumab Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR DARATUMUMAB BY GEOGRAPHIC REGION

4.1 World Historic Daratumumab Market Size by Geographic Region (2018-2023)
  4.1.1 Global Daratumumab Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Daratumumab Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Daratumumab Market Size by Country/Region (2018-2023)
  4.2.1 Global Daratumumab Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Daratumumab Annual Revenue by Country/Region (2018-2023)
4.3 Americas Daratumumab Sales Growth
4.4 APAC Daratumumab Sales Growth
4.5 Europe Daratumumab Sales Growth
4.6 Middle East & Africa Daratumumab Sales Growth

5 AMERICAS

5.1 Americas Daratumumab Sales by Country
  5.1.1 Americas Daratumumab Sales by Country (2018-2023)
  5.1.2 Americas Daratumumab Revenue by Country (2018-2023)
5.2 Americas Daratumumab Sales by Type
5.3 Americas Daratumumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Daratumumab Sales by Region
  6.1.1 APAC Daratumumab Sales by Region (2018-2023)
  6.1.2 APAC Daratumumab Revenue by Region (2018-2023)
6.2 APAC Daratumumab Sales by Type
6.3 APAC Daratumumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Daratumumab by Country
  7.1.1 Europe Daratumumab Sales by Country (2018-2023)
  7.1.2 Europe Daratumumab Revenue by Country (2018-2023)
7.2 Europe Daratumumab Sales by Type
7.3 Europe Daratumumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Daratumumab by Country
  8.1.1 Middle East & Africa Daratumumab Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Daratumumab Revenue by Country (2018-2023)
8.2 Middle East & Africa Daratumumab Sales by Type
8.3 Middle East & Africa Daratumumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Daratumumab
10.3 Manufacturing Process Analysis of Daratumumab
10.4 Industry Chain Structure of Daratumumab

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Daratumumab Distributors
11.3 Daratumumab Customer

12 WORLD FORECAST REVIEW FOR DARATUMUMAB BY GEOGRAPHIC REGION

12.1 Global Daratumumab Market Size Forecast by Region
  12.1.1 Global Daratumumab Forecast by Region (2024-2029)
  12.1.2 Global Daratumumab Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Daratumumab Forecast by Type
12.7 Global Daratumumab Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Johnson?Johnson
  13.1.1 Johnson?Johnson Company Information
  13.1.2 Johnson?Johnson Daratumumab Product Portfolios and Specifications
  13.1.3 Johnson?Johnson Daratumumab Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Johnson?Johnson Main Business Overview
  13.1.5 Johnson?Johnson Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Daratumumab Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Daratumumab Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 100mg Injection
Table 4. Major Players of 400mg Injection
Table 5. Global Daratumumab Sales by Type (2018-2023) & (K Pcs)
Table 6. Global Daratumumab Sales Market Share by Type (2018-2023)
Table 7. Global Daratumumab Revenue by Type (2018-2023) & ($ million)
Table 8. Global Daratumumab Revenue Market Share by Type (2018-2023)
Table 9. Global Daratumumab Sale Price by Type (2018-2023) & (USD/Pcs)
Table 10. Global Daratumumab Sales by Application (2018-2023) & (K Pcs)
Table 11. Global Daratumumab Sales Market Share by Application (2018-2023)
Table 12. Global Daratumumab Revenue by Application (2018-2023)
Table 13. Global Daratumumab Revenue Market Share by Application (2018-2023)
Table 14. Global Daratumumab Sale Price by Application (2018-2023) & (USD/Pcs)
Table 15. Global Daratumumab Sales by Company (2018-2023) & (K Pcs)
Table 16. Global Daratumumab Sales Market Share by Company (2018-2023)
Table 17. Global Daratumumab Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Daratumumab Revenue Market Share by Company (2018-2023)
Table 19. Global Daratumumab Sale Price by Company (2018-2023) & (USD/Pcs)
Table 20. Key Manufacturers Daratumumab Producing Area Distribution and Sales Area
Table 21. Players Daratumumab Products Offered
Table 22. Daratumumab Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Daratumumab Sales by Geographic Region (2018-2023) & (K Pcs)
Table 26. Global Daratumumab Sales Market Share Geographic Region (2018-2023)
Table 27. Global Daratumumab Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Daratumumab Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Daratumumab Sales by Country/Region (2018-2023) & (K Pcs)
Table 30. Global Daratumumab Sales Market Share by Country/Region (2018-2023)
Table 31. Global Daratumumab Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Daratumumab Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Daratumumab Sales by Country (2018-2023) & (K Pcs)
Table 34. Americas Daratumumab Sales Market Share by Country (2018-2023)
Table 35. Americas Daratumumab Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Daratumumab Revenue Market Share by Country (2018-2023)
Table 37. Americas Daratumumab Sales by Type (2018-2023) & (K Pcs)
Table 38. Americas Daratumumab Sales by Application (2018-2023) & (K Pcs)
Table 39. APAC Daratumumab Sales by Region (2018-2023) & (K Pcs)
Table 40. APAC Daratumumab Sales Market Share by Region (2018-2023)
Table 41. APAC Daratumumab Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Daratumumab Revenue Market Share by Region (2018-2023)
Table 43. APAC Daratumumab Sales by Type (2018-2023) & (K Pcs)
Table 44. APAC Daratumumab Sales by Application (2018-2023) & (K Pcs)
Table 45. Europe Daratumumab Sales by Country (2018-2023) & (K Pcs)
Table 46. Europe Daratumumab Sales Market Share by Country (2018-2023)
Table 47. Europe Daratumumab Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Daratumumab Revenue Market Share by Country (2018-2023)
Table 49. Europe Daratumumab Sales by Type (2018-2023) & (K Pcs)
Table 50. Europe Daratumumab Sales by Application (2018-2023) & (K Pcs)
Table 51. Middle East & Africa Daratumumab Sales by Country (2018-2023) & (K Pcs)
Table 52. Middle East & Africa Daratumumab Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Daratumumab Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Daratumumab Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Daratumumab Sales by Type (2018-2023) & (K Pcs)
Table 56. Middle East & Africa Daratumumab Sales by Application (2018-2023) & (K Pcs)
Table 57. Key Market Drivers & Growth Opportunities of Daratumumab
Table 58. Key Market Challenges & Risks of Daratumumab
Table 59. Key Industry Trends of Daratumumab
Table 60. Daratumumab Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Daratumumab Distributors List
Table 63. Daratumumab Customer List
Table 64. Global Daratumumab Sales Forecast by Region (2024-2029) & (K Pcs)
Table 65. Global Daratumumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Daratumumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 67. Americas Daratumumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Daratumumab Sales Forecast by Region (2024-2029) & (K Pcs)
Table 69. APAC Daratumumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Daratumumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 71. Europe Daratumumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Daratumumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Middle East & Africa Daratumumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Daratumumab Sales Forecast by Type (2024-2029) & (K Pcs)
Table 75. Global Daratumumab Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Daratumumab Sales Forecast by Application (2024-2029) & (K Pcs)
Table 77. Global Daratumumab Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Johnson?Johnson Basic Information, Daratumumab Manufacturing Base, Sales Area and Its Competitors
Table 79. Johnson?Johnson Daratumumab Product Portfolios and Specifications
Table 80. Johnson?Johnson Daratumumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 81. Johnson?Johnson Main Business
Table 82. Johnson?Johnson Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Daratumumab
Figure 2. Daratumumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Daratumumab Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Daratumumab Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Daratumumab Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 100mg Injection
Figure 10. Product Picture of 400mg Injection
Figure 11. Global Daratumumab Sales Market Share by Type in 2022
Figure 12. Global Daratumumab Revenue Market Share by Type (2018-2023)
Figure 13. Daratumumab Consumed in Multiple Myeloma
Figure 14. Global Daratumumab Market: Multiple Myeloma (2018-2023) & (K Pcs)
Figure 15. Daratumumab Consumed in Diffuse Large B Cell Lymphoma
Figure 16. Global Daratumumab Market: Diffuse Large B Cell Lymphoma (2018-2023) & (K Pcs)
Figure 17. Daratumumab Consumed in Follicular Lymphoma
Figure 18. Global Daratumumab Market: Follicular Lymphoma (2018-2023) & (K Pcs)
Figure 19. Daratumumab Consumed in Mantle Cell Lymphoma
Figure 20. Global Daratumumab Market: Mantle Cell Lymphoma (2018-2023) & (K Pcs)
Figure 21. Daratumumab Consumed in Other
Figure 22. Global Daratumumab Market: Other (2018-2023) & (K Pcs)
Figure 23. Global Daratumumab Sales Market Share by Application (2022)
Figure 24. Global Daratumumab Revenue Market Share by Application in 2022
Figure 25. Daratumumab Sales Market by Company in 2022 (K Pcs)
Figure 26. Global Daratumumab Sales Market Share by Company in 2022
Figure 27. Daratumumab Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Daratumumab Revenue Market Share by Company in 2022
Figure 29. Global Daratumumab Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Daratumumab Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Daratumumab Sales 2018-2023 (K Pcs)
Figure 32. Americas Daratumumab Revenue 2018-2023 ($ Millions)
Figure 33. APAC Daratumumab Sales 2018-2023 (K Pcs)
Figure 34. APAC Daratumumab Revenue 2018-2023 ($ Millions)
Figure 35. Europe Daratumumab Sales 2018-2023 (K Pcs)
Figure 36. Europe Daratumumab Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Daratumumab Sales 2018-2023 (K Pcs)
Figure 38. Middle East & Africa Daratumumab Revenue 2018-2023 ($ Millions)
Figure 39. Americas Daratumumab Sales Market Share by Country in 2022
Figure 40. Americas Daratumumab Revenue Market Share by Country in 2022
Figure 41. Americas Daratumumab Sales Market Share by Type (2018-2023)
Figure 42. Americas Daratumumab Sales Market Share by Application (2018-2023)
Figure 43. United States Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Daratumumab Sales Market Share by Region in 2022
Figure 48. APAC Daratumumab Revenue Market Share by Regions in 2022
Figure 49. APAC Daratumumab Sales Market Share by Type (2018-2023)
Figure 50. APAC Daratumumab Sales Market Share by Application (2018-2023)
Figure 51. China Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Daratumumab Sales Market Share by Country in 2022
Figure 59. Europe Daratumumab Revenue Market Share by Country in 2022
Figure 60. Europe Daratumumab Sales Market Share by Type (2018-2023)
Figure 61. Europe Daratumumab Sales Market Share by Application (2018-2023)
Figure 62. Germany Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Daratumumab Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Daratumumab Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Daratumumab Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Daratumumab Sales Market Share by Application (2018-2023)
Figure 71. Egypt Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Daratumumab Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Daratumumab in 2022
Figure 77. Manufacturing Process Analysis of Daratumumab
Figure 78. Industry Chain Structure of Daratumumab
Figure 79. Channels of Distribution
Figure 80. Global Daratumumab Sales Market Forecast by Region (2024-2029)
Figure 81. Global Daratumumab Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Daratumumab Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Daratumumab Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Daratumumab Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Daratumumab Revenue Market Share Forecast by Application (2024-2029)